Millions Suffer from NeuroGenetic Diseases.
We’re Building Therapies That Actually Reach the Brain.
NanoMedX is pioneering gene therapies using CRISPR-based prime editing system, RNA technologies, and an advanced nano-delivery system engineered to address the underlying causes of neurological disorders without systemic side effects.
The Problem: Therapies Don’t Reach the Brain
Traditional treatments for neurodegenerative diseases often fail because they can't effectively reach the brain or address the underlying cause.
Patients and families are left with invasive procedures, systemic side effects, or no options at all.
At NanoMedX, we believe there’s a better way — and we’re building it.
A 3-Part Gene Therapy Platform That Actually Reaches the Brain
Most therapeutics can’t effectively reach the brain.
Our 3-part gene therapy ecosystem overcomes this challenge—non-invasively—by combining:
CRISPR-based prime editing system for precision genetic engineering at the molecular level.
A targeted precision nanomedicine delivery system that bypasses the blood-brain barrier and accurately transports biologics to specific brain regions.
A personalized intranasal device designed to administer treatment directly to the brain.
This layered ecosystem delivers our therapeutics and prophylactics with 98.6% accuracy, achieving the desired genetic expression without invasive procedures or repeat dosing—and with near-zero toxicity or immune response.
CRISPR Prime Editing
Repairs DNA mutations with unmatched accuracy.
Designed to minimize off-target effects for safer gene therapy.
RNA Formulations
Enables precise and intended gene expression with targeted control to treat complex neurological conditions like Alzheimer’s, Parkinson’s, and some forms of Autism Spectrum Disorder.
Intranasal Nano-Delivery
Our patented intranasal nano-delivery system bypasses the blood-brain barrier to deliver treatment directly—no injections required.
What This Means for Patients
Our therapies are designed to address the root causes of complex neurological conditions.
From restoring movement to preserving cognition and improving communication, our mission is to bring new hope through science that truly reaches the brain.
Alzheimer’s: Protecting Memory and Cognitive Function
Our goal is to prevent, slow, or even halt the progression of Alzheimer’s disease—and ultimately, work toward a cure.
Parkinson’s: Restoring Movement and Everyday Confidence
We are developing therapies that aim to reduce tremors, improve mobility, and give patients greater control over their daily lives.
Autism: Supporting Communication and Connection
Our RNA-based nanomedicine are designed to support social development and behavioral outcomes — giving families new pathways for care.
Innovative Biotech Solutions for Gene Therapy Advancements
We are a pioneering biotech company focused on transforming healthcare through cutting-edge gene therapies and nanotechnology. Our mission is to harness the power of CRISPR technology to develop safe and effective treatments.
Our Vision
To revolutionize medicine with innovative, gene therapy solutions for all.
Our Approach
We utilize advanced CRISPR-based genetic engineering tools and nanomaterials to precisely deliver our biologics to targeted sites in the brain—enhancing therapeutic impact where it’s needed most.
